1 TAMSULOSIN HCL | 350 of 1830 | 5810 prescriptions Less than 1% of all prescriptions | | 1410 patients 32% of all patients | < 11 | |
2 FINASTERIDE | 560 of 1700 | 2440 prescriptions Less than 1% of all prescriptions | 2280 | 700 patients 16% of all patients | < 11 | |
3 TESTOSTERONE CYPIONATE | 60 of 700 | 720 prescriptions Less than 1% of all prescriptions | | 220 patients 5% of all patients | < 11 | |
4 TERAZOSIN HCL | 120 of 700 | 590 prescriptions Less than 1% of all prescriptions | 590 | 150 patients 3% of all patients | 150 patients 3% of all patients | |
5 DUTASTERIDE | 70 of 660 | 600 prescriptions Less than 1% of all prescriptions | 600 | 150 patients 3% of all patients | 150 patients 3% of all patients | |
6 POTASSIUM CITRATE ER (POTASSIUM CITRATE) | 250 of 860 | 390 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
7 ANDROGEL (TESTOSTERONE) | 10 of 330 | 570 prescriptions Less than 1% of all prescriptions | 570 | 170 patients 4% of all patients | 170 patients 4% of all patients | |
8 MYRBETRIQ (MIRABEGRON) | 640 of 1470 | 440 prescriptions Less than 1% of all prescriptions | 440 | 160 patients 4% of all patients | 160 patients 4% of all patients | |
9 BICALUTAMIDE | 190 of 700 | 290 prescriptions Less than 1% of all prescriptions | 290 | < 11 | < 11 | |
10 TOVIAZ (FESOTERODINE FUMARATE) | 70 of 510 | 350 prescriptions Less than 1% of all prescriptions | 350 | < 11 | < 11 | |
11 DOXAZOSIN MESYLATE | 350 of 790 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
12 VESICARE (SOLIFENACIN SUCCINATE) | 430 of 1190 | 320 prescriptions Less than 1% of all prescriptions | 320 | < 11 | < 11 | |
13 XTANDI (ENZALUTAMIDE) | 30 of 150 | 370 prescriptions Less than 1% of all prescriptions | 370 | < 11 | < 11 | |
14 TESTOSTERONE | 30 of 190 | 260 prescriptions Less than 1% of all prescriptions | 260 | 130 patients 3% of all patients | 130 patients 3% of all patients | |
15 ANASTROZOLE | 50 of 110 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
16 TOLTERODINE TARTRATE ER (TOLTERODINE TARTRATE) | 250 of 410 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
17 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 700 of 1590 | 230 prescriptions Less than 1% of all prescriptions | 230 | 140 patients 3% of all patients | 140 patients 3% of all patients | A |
18 TROSPIUM CHLORIDE ER (TROSPIUM CHLORIDE) | 70 of 150 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
19 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 100 of 800 | 500 prescriptions Less than 1% of all prescriptions | 500 | 260 patients 6% of all patients | 260 patients 6% of all patients | A |
20 CEPHALEXIN | 540 of 1160 | 410 prescriptions Less than 1% of all prescriptions | | 310 patients 7% of all patients | < 11 | A |
21 ALFUZOSIN HCL ER (ALFUZOSIN HCL) | 540 of 880 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 CABERGOLINE | 10 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
23 CIPROFLOXACIN HCL | 370 of 1580 | 1550 prescriptions Less than 1% of all prescriptions | | 1220 patients 28% of all patients | < 11 | A |
24 NITROFURANTOIN (NITROFURANTOIN MACROCRYSTAL) | 450 of 760 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | A |
25 AMPICILLIN TRIHYDRATE | 60 of 90 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | A |
26 CEFDINIR | 180 of 230 | 160 prescriptions Less than 1% of all prescriptions | 160 | 150 patients 3% of all patients | 150 patients 3% of all patients | A |
27 OXYCODONE-ACETAMINOPHEN (OXYCODONE HCL/ACETAMINOPHEN) | 400 of 750 | 180 prescriptions Less than 1% of all prescriptions | | 180 patients 4% of all patients | < 11 | O |
28 LORAZEPAM | 10 of 20 | 240 prescriptions Less than 1% of all prescriptions | | 220 patients 5% of all patients | < 11 | |
29 KETOROLAC TROMETHAMINE | 10 | 210 prescriptions Less than 1% of all prescriptions | 210 | 210 patients 5% of all patients | 210 patients 5% of all patients | |